GyroGlove Use in Essential Tremor Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Essential Tremor
Interventions
DEVICE

Placebo

The placebo device consists of the same hardware as GyroGlove: aesthetically it looks the same, weight same and produces the same noise as GyroGlove. Participants will interact with Placebo on the day of baseline visit (i.e. Day 0).

DEVICE

GyroGlove

GyroGlove is a patented wearable device containing high-performance, miniaturised, gyroscopes designed for individuals diagnosed with essential tremor. Participants will interact with GyroGlove on the day of baseline visit (i.e. Day 0), 2-week Home use and on the day of follow-up visit (i.e Day 14).

Trial Locations (7)

48334

Quest Research Institute, Farmington Hills

77030

Houston Methodist Stanley H. Appel Department of Neurology, Houston

05401

University of Vermont Medical Centre, Burlington

CB2 0QQ

Addenbrooke Hospital, Cambridge University Hospital NHS Trust, Cambridge

NE4 5PL

Clinical Ageing Research Unit, Newcastle University, Newcastle

OX3 9DU

Oxford University Hospitals NHS Foundation Trust, UK, Oxford

NE29 8NH

North Tyneside General Hospital, Newcastle

All Listed Sponsors
lead

GyroGear Ltd

INDUSTRY